University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies:
Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors
Epitel, a leader in AI technologies for patient-focused brain health solutions, announced the addition of wearables industry pioneer Ken Nelson to its Board of Directors. With his extensive experience in digital health, medical devices, and remote patient monitoring, Nelson will play a crucial role in guiding Epitel's growth as the company continues to transform the landscape of brain monitoring through AI/ML and its wearable EEG technology.
Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight® Mental Health Monitor: Special Election Series, a nationwide survey from Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine.
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
Recursion Pharmaceuticals, Inc., a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced the pricing of its underwritten public offering of 30,769,230 shares of its Class A common stock at a price to the public of $6.50 per share.
SymbioCellTech Named One Winner of The American Diabetes Association Diabetes Innovation Challenge
.The American Diabetes Association ® (ADA) announced the winners of its Innovation Challenge competition. Innovators showcased novel ideas for diabetes care before a panel of potential funders and an audience of professionals in the field, with the goal of furthering transformative solutions for people living with diabetes, their families, and caregivers. Five finalists pitched ideas from the main stage at the ADA’s 84th Scientific Sessions and three winners were chosen— Diatech Diabetes, Spotlight Communications, and SymbioCellTech.
